Skip to main content

Supplement evidence guide

Kava: Anxiety Evidence, Forms and Liver Safety

Kava is Piper methysticum, a plant used in traditional beverages and extracts. Anxiety findings differ, and rare serious liver injury makes safety central to the discussion.

Published by LongevityMate Editorial · Updated 2026-10-15 · 3 minute read

The short answer

What this guide helps you understand

Kava has mixed anxiety evidence: older trials suggested symptom benefits, while a longer diagnosed-anxiety trial found no benefit. Rare serious liver injury remains a concern.See reference 1,See reference 2,See reference 3

Original generated ingredient illustration of a textured kava root crown, chopped root and broad heart-shaped leaves; not a verified specimen, purity test or safety guarantee.
On this page

One plant, several preparations

Kava is Piper methysticum, a South Pacific plant. Water-prepared drinks, whole root and extracts standardized for kavalactones are different preparations and amounts.See reference 1,See reference 3

The original ingredient illustration depicts roots and broad leaves. It is not a verified specimen, purity test or proof that a preparation is safe.

Why the evidence summaries differ

Evidence
Historical Cochrane review, 2003
What it assessed
12 trials, 700 participants; 7 trials entered the pooled anxiety-score analysis
Finding and limit
Small favorable signal with limited robustness; it predates the larger 2020 trialSee reference 2
Evidence
2020 longer randomized trial
What it assessed
171 non-medicated participants with diagnosed generalized anxiety disorder; 16 weeks
Finding and limit
No significant anxiety benefit versus placebo for the tested aqueous root extractSee reference 3
Evidence
Current NCCIH summary, 2025
What it assessed
Anxiety evidence and reported safety problems
Finding and limit
Possible benefit for some anxiety symptoms does not establish benefit for generalized anxiety disorder or other conditionsSee reference 1

An aqueous extract was not automatically effective or free of concerns

The 2020 trial tested a water-based dried-root extract providing 120 mg kavalactones twice daily. This research amount is not personal dosing advice.See reference 3

Abnormal liver tests, memory difficulties and tremor were more frequent with kava, although no participant met the study’s herb-induced liver-injury criteria. This result cannot establish safety for all water preparations.See reference 3

A positive old review cannot settle today’s product choice

The Cochrane review was based on relatively small trials and said the effect lacked robustness. Short studies with few participants are poorly suited to ruling out rare or long-term harms. Treat its positive signal as historical evidence with limits, rather than current assurance that kava is safer than established anxiety care.See reference 2

Keep rare serious liver injury in the main discussion

NCCIH reports rare serious and fatal liver injuries, including cases involving water-prepared drinks. Proposed contributors include cultivar, plant parts, contamination, alcohol, prolonged use and susceptibility; the cause is unsettled.See reference 1

Reports of liver injury and trial liver-test abnormalities are different evidence. Neither supplies a personal risk estimate or clearance for liver disease.See reference 1,See reference 3

Sedative combinations need particular caution

NCCIH cautions against alcohol or other sedating combinations, including benzodiazepines, and describes pregnancy or breastfeeding risks. Digestive symptoms and dizziness are also reported. Discuss medicines and supplements with the treating professional.See reference 1

Product identification does not establish suitability

Keep the species, plant part, extraction method, kavalactone amount and other ingredients available for a professional review. A quality check helps assess what is being sold. It does not demonstrate that the bottle is effective for diagnosed anxiety or has the safety profile of a different study preparation.See reference 4

Keep the useful details

Common questions

Did the longer generalized-anxiety trial show a benefit?

No statistically significant benefit versus placebo was found for the tested aqueous extract over 16 weeks.See reference 3

Does an older favorable review mean kava is proven for everyone?

No. Its small, older trials and limited robustness do not settle the newer diagnosed-population question.See reference 2

Does water preparation remove all liver concerns?

No. Water-prepared drinks have been implicated in liver-injury reports, and abnormal liver tests occurred in the trial.See reference 1,See reference 3

Get the weekly longevity brief

The week's best longevity research in plain English. Free, every Tuesday.

References

  1. 1. Kava: usefulness and safety

    NCCIH; updated April 2025Official guidance

  2. 2. Kava extract versus placebo for treating anxiety

    Pittler and Ernst, Cochrane; historical 2003 reviewSystematic review

  3. 3. Kava for generalised anxiety disorder: a 16-week randomized placebo-controlled study

    Sarris et al., Australian & New Zealand Journal of Psychiatry, 2020Randomized trial

  4. 4. Using dietary supplements wisely

    NCCIHOfficial guidance

Editorial transparency

Published by
LongevityMate Editorial
Published
Updated

Medical disclaimer

General education only. This guide does not diagnose a condition, interpret your personal result, choose a treatment or recommend a supplement dose. Discuss testing, symptoms, medicines and supplements with a qualified health professional.